Advestra acted as legal counsel to Sequotech on its partnership with EVOK, an IT services provider based in Fribourg. Nexus Attorneys advised the shareholders of ALTERN8 – EVOK on the transaction.
Tags :Advestra
Advestra advised Novartis on the issuance of CHF 2.2 billion bonds, placed in five tranches as follows: UBS, BNP Paribas (Suisse) and Deutsche Bank Aktiengesellschaft acted as joint lead managers
Advestra advised Barry Callebaut on the placement of CHF 730 million bonds in the Swiss market on 17 May 2024. In addition, Barry Callebaut issued Eurobonds in the amount of EUR 700 mil
Advestra advised Viseca on the placement of CHF 165 million 1.65% senior bonds due 2028, which were issued by Viseca Payment Services. Zürcher Kantonalbank, Raiffeisen Schweiz
Advestra advised Wille Finance, an international Swiss-based family office focusing on private equity / venture capital, real estate and listed assets, on its anchor investment in SwissComply, a provider of outsourcing solutions for
Advestra advised Cactus life sciences, a global scientific communications agency that works with blue chip pharma and biotechnology companies, on nspm and eluSCIdate’
Advestra advised UBS on EUR 300 million rights offering by Swiss Steel. The transaction consisted in an offering of subscription rights and a placement of shares on which rights
DocMorris (former Zur Rose Group) successfully placed CHF 200 million senior unsecured guaranteed convertible bonds due 2029. The bonds were issued by a Dutch subsi
Meyer Burger Technology has successfully completed a capital increase raising gross proceeds of approximately CHF 207 million. The transaction con
Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company pioneering allosteric modulation-based drug development,
